Clinical Trials Browser

Phase NA × Not yet recruiting × Ototoxicity × Clear all

Ototoxicity, Deglutition Disorders, Head and Neck Neoplasms, Hearing Loss, Sensorineural, Tinnitus, Hearing Loss, Drug-Related Side Effects and Adverse Reactions

NCT06957132 2025-05-04

RISP-OTOTOX

Phase NA Not yet recruiting

500 enrolled

Ototoxicity, Neoplasms

Clinical Trials

TIMELY REHAB

RISP-OTOTOX